Watch for New "Follow-On" Mealtime Insulin Admelog (Lispro)
Admelog (AD-mah-log) will compete with Humalog as a new BRAND of insulin lispro.
This is similar to the situation with Basaglar and Lantus.
Admelog is not a generic...and isn't technically a biosimilar in the U.S. Instead, FDA calls Admelog and Basaglar "follow-on" brands...they use safety and efficacy data from the original brands for faster approval.